Table 3.

Results for the longitudinal part of the JM analysis and the LMM analysis (under missingness at random) of the HERS data^a

	Results for the JM						Results for the LMM
	Bayesian analysis			MLE analysis			Estimate	2.5%	97.5%
	Mean	2.5%	97.5%	Estimate	2.5%	97.5%
Intercept	15.080	13.700	16.410	14.901	14.267	15.509	14.589	13.208	15.969
Time (visit)	−0.863	−1.105	−0.628	−0.902	−1.024	−0.795	−0.574	−0.803	−0.344
Baseline HIV viral load (copies ml−1)
0–500	10.040	8.495	11.550	10.035	9.115	10.956	10.520	8.974	12.066
500–5000	6.623	5.175	8.020	6.605	5.764	7.288	6.985	5.530	8.440
5000–30000	2.977	1.464	4.519	2.946	1.907	3.907	3.210	1.611	4.808
>30000	Reference			Reference			Reference
Baseline HIV symptoms	−0.115	−0.513	0.268	−0.182	−0.614	0.234	−0.142	−0.550	0.265
Antiretroviral therapy	−4.653	−5.485	−3.814	−4.815	−5.719	−3.990	−4.760	−5.600	−3.920
at baseline
Time * baseline viral load (copies ml−1)
0–500	0.464	0.207	0.734	0.463	0.319	0.597	0.232	−0.016	0.480
500–5000	0.433	0.183	0.684	0.422	0.311	0.533	0.220	−0.019	0.459
5000–30000	0.273	0.003	0.547	0.266	0.104	0.424	0.153	−0.108	0.414
>30000	Reference			Reference			Reference
Time * baseline	−0.049	−0.107	0.013	−0.054	−0.117	0.010	−0.027	−0.086	0.032
HIV symptoms
Time * antiretroviral	0.109	−0.011	0.229	0.105	−0.027	0.223	0.159	0.040	0.279
therapy at baseline
corr(b i1,b i2)	−0.305	−0.380	−0.229	—	—	—	−0.343	—	—
var(b i1)	29.120	26.000	32.520	—	—	—	29.284	—	—
var(b i2)	0.539	0.467	0.622	—	—	—	0.450	—	—
${\mathit{\sigma }}_{\mathit{ϵ}}^2$	7.304	7.026	7.583	—	—	—	7.345	—	—

^aFor results from the Bayesian approach, we present the posterior mean, standard deviation and 95% credible intervals. For the maximum profile likelihood estimation results, we provide point estimates and 95% confidence intervals.